IRIS
FRANZESE, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.038
AS - Asia 5.700
EU - Europa 1.992
SA - Sud America 1.396
AF - Africa 274
Continente sconosciuto - Info sul continente non disponibili 235
OC - Oceania 25
Totale 18.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.864
SG - Singapore 3.397
BR - Brasile 1.129
CN - Cina 975
VN - Vietnam 664
IT - Italia 497
FI - Finlandia 298
DE - Germania 290
IE - Irlanda 234
HK - Hong Kong 163
NG - Nigeria 154
FR - Francia 126
GB - Regno Unito 114
IN - India 107
AR - Argentina 101
CA - Canada 91
NL - Olanda 87
SE - Svezia 85
BD - Bangladesh 60
RU - Federazione Russa 58
EC - Ecuador 44
ID - Indonesia 43
TR - Turchia 43
MX - Messico 42
CO - Colombia 36
ZA - Sudafrica 34
IQ - Iraq 32
ES - Italia 28
IL - Israele 28
PL - Polonia 27
VE - Venezuela 27
CL - Cile 26
UA - Ucraina 25
AU - Australia 24
BE - Belgio 22
UZ - Uzbekistan 21
PK - Pakistan 19
SA - Arabia Saudita 18
MA - Marocco 16
AT - Austria 15
KE - Kenya 14
PY - Paraguay 14
EG - Egitto 13
JP - Giappone 13
RO - Romania 13
CZ - Repubblica Ceca 12
TN - Tunisia 12
PE - Perù 11
AZ - Azerbaigian 10
DZ - Algeria 10
KZ - Kazakistan 10
LT - Lituania 10
MY - Malesia 10
NP - Nepal 10
OM - Oman 10
JO - Giordania 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
HN - Honduras 8
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
BG - Bulgaria 6
IR - Iran 6
PS - Palestinian Territory 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NO - Norvegia 5
RS - Serbia 5
BO - Bolivia 4
GE - Georgia 4
HR - Croazia 4
JM - Giamaica 4
SN - Senegal 4
AM - Armenia 3
BB - Barbados 3
BS - Bahamas 3
CH - Svizzera 3
CI - Costa d'Avorio 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
Totale 18.409
Salva come PNG Salva come JPEG
Città #
Singapore 1.510
Wilmington 1.084
Dallas 955
Chandler 761
Ashburn 584
The Dalles 477
San Mateo 411
Shanghai 403
San Jose 383
Helsinki 296
Council Bluffs 290
Ann Arbor 287
Beijing 235
Dublin 232
Ho Chi Minh City 232
Leawood 198
Boardman 196
Princeton 192
Lawrence 186
Milan 185
New York 174
Hanoi 157
Benin City 153
Hong Kong 138
Woodbridge 122
Falkenstein 118
Santa Clara 108
Fairfield 107
São Paulo 102
Los Angeles 100
Paris 96
Amsterdam 70
Buffalo 64
Rome 63
London 53
Rio de Janeiro 44
Toronto 40
Phoenix 38
Seattle 38
Orem 34
Da Nang 32
Norwalk 28
Belo Horizonte 27
Chennai 27
Haiphong 27
Figino 25
Kocaeli 25
Naples 22
Charlotte 21
Chicago 21
Brussels 20
Porto Alegre 20
Warsaw 20
Miami 19
San Diego 19
Mexico City 17
Tashkent 17
Brasília 16
Brooklyn 16
Curitiba 16
Fortaleza 16
Guayaquil 16
Monmouth Junction 16
Munich 16
Johannesburg 15
Montreal 15
Can Tho 14
Boston 13
Milwaukee 13
Moscow 13
Philadelphia 13
Ribeirão Preto 13
Tokyo 13
Baghdad 12
Biên Hòa 12
Dhaka 12
Hải Dương 12
Manchester 12
Pune 12
Des Moines 11
Hillsboro 11
Nairobi 11
Quito 11
Stockholm 11
Madrid 10
Ninh Bình 10
Salvador 10
San Francisco 10
Santo André 10
Baku 9
Bogotá 9
Columbus 9
Guarulhos 9
Nova Iguaçu 9
Nuremberg 9
Phủ Lý 9
Thái Bình 9
Thái Nguyên 9
Turin 9
Asunción 8
Totale 11.812
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 762
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 151
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 148
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 133
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 126
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 122
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 120
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 119
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 118
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 116
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 113
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 111
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 111
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 107
Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: a single centre experience 106
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 105
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 105
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 105
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 105
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 104
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 104
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 99
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach 99
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 98
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 96
Hypofractionated stereotactic radiation therapy in skull base meningiomas 94
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 94
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 93
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 92
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy 91
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 90
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 88
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 88
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 88
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 87
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 87
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO‐Head and Neck working group 85
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 85
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 85
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 85
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 84
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 84
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 84
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 84
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-years toxicity and clinical results 83
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 83
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 83
Imaging biomarkers in primary brain tumours 82
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 81
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 81
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 80
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 80
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 80
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 79
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 79
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 79
Efficacy and safety of re-irradiation of locally recurrent prostate cancer with FFF-VMAT 79
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 78
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 78
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 78
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 77
Critical re-evaluation of a failure mode effect analysis in a radiation therapy department after ten years 77
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 76
RapidPlan head and neck model: the objectives and possible clinical benefit. 76
Results of a feed-back learning process for RapidPlan knowledge based planning 76
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome 76
Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis 75
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 75
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 75
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 75
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 75
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 74
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 74
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 74
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 74
Role of C-11-CHOLINE PET/CT in the Radiotherapy Treatment Planning of Prostate Cancer Patients 74
Radiotherapy and Immunotherapies in elderly: a systematic literature review 74
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity 74
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 74
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 73
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 73
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 73
Role of SBRT with VMAT-FFF for abdomino-pelvic lymph node metastases in oligometastatic patients 73
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 73
Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question 72
SBRT for oligometastatic gynecological cancer: a single institution experience 72
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 72
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 72
Stereotactic Body Radiation Therapy for oligometastatic patients with ovarian cancer 72
Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies 72
Low Prevalence of K-RAS, EGF-R and BRAF Mutations in Sinonasal Adenocarcinomas. Implications for Anti-EGFR Treatments 72
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality 72
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis 72
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 71
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 71
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 71
LINAC-BASED STEREOTACTIC RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW-UP UPDATE ON TOXICITY AND SURVIVAL 71
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 71
Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer 71
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 70
Totale 9.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022921 0 7 8 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.463 72 167 327 80 45 145 58 70 70 32 152 245
2024/20252.459 51 89 33 33 23 276 121 226 381 644 254 328
2025/20268.314 1.025 610 1.003 1.060 214 289 1.819 559 434 431 283 587
2026/20271.111 533 578 0 0 0 0 0 0 0 0 0 0
Totale 18.660